Skip to main content
OpenTrials
Completed

NCT Number: NCT01378130

Central Serous Chorioretinopathy: Etiology, Course and Prognosis

Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Central Serous Chorioretinopathy Eye Diseases Retinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Vienna Gerenal Hospital

Vienna, Austria

About this study

Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed informed consent form
  • Age over 18 years
  • acute episode of Central Serous Chorioretinopathy
  • Symptoms for less than two weeks
  • no treatment on study eye

Exclusion criteria

  • bad compliance
  • protected patient group (pregnant women)

Treatment and study plan

Primary outcomes

  1. Clinical Outcome

    Time frame: 2 years

    OCT, Visus

Secondary outcomes

  1. Subclinical Data

    Time frame: 2 years

    FA findings, retinal sensitivity in Microperimetry, contrast sensitivity, Amsler Grid Test

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Jun 22, 2011
Registry last updated
Apr 26, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.